Introduction: Radiosensitization by hyperthermia

International Journal of Hyperthermia

Volumn 20, Issue 2, 2004, Pages 109-114

  Roti Roti, J L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; DOUBLE STRANDED DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MRE11 PROTEIN; RAD50 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1;

BRACHYTHERAPY; CELL DAMAGE; CELL KILLING; CELL SURVIVAL; CHEMOSENSITIVITY; COMPLEX FORMATION; DNA BINDING; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; DRUG SENSITIVITY; EDITORIAL; EXCISION REPAIR; HEAT SHOCK; HEAT STRESS; HYPERTHERMIA; IONIZING RADIATION; MEDICAL RESEARCH; OXIDATION REDUCTION REACTION; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN STABILITY; RADIATION DOSE; RADIATION EXPOSURE; RADIOIMMUNOTHERAPY; RADIOSENSITIVITY; RADIOSENSITIZATION; RADIOTHERAPY; SIGNAL TRANSDUCTION; THERMAL EXPOSURE; THERMAL INJURY; TUMOR; TUMOR CELL;

HEAT-SHOCK RESPONSE; HUMANS; HYPERTHERMIA, INDUCED; NEOPLASMS; RADIATION TOLERANCE;

EID: 1842525216     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.1080/0265673032000173898     Document Type: Editorial

References (23)

1. Myerson RJ, Moros E, Roti Roti JL. Hyperthermia. In: Perez CA, Brady LW, eds. Principles and Practice of Radiation Oncology. Philadelphia: Lippincott-Raven Publishers, 1977; 637-84.
2. Atkinson BG, Walden DB. Changes in Gene Expression in Response to Environmental Stress. New York: Academic Press, 1985.
3. Urano M, Douple EB. Thermal effects on cells and tissues. In: Urano M, Douple E, eds. Hyperthermia and Oncology, Volume 1. Utrecht, The Netherlands: VSP, 1988; 1-216.
4. Urano M, Douple EB. Biology of the thermal potentiation of radiotherapy. In: Urano M, Douple E, eds. Hyperthermia and Oncology, Volume 2, Utrecht, The Netherlands: VSP, 1989; 1-176.
5. Urano M, Douple EB. Interstitial hyperthermia: Physics, biology and clinical aspects. In: Urano M, Douple E, eds. Hyperthermia and Oncology, Volume 3, Utrecht, The Netherlands: VSP, 1992; 1-348.
6. Urano M, Douple EB. Chemopotentiation by hyperthermia. In: Urano M, Douple E, eds. Hyperthermia and Oncology, Volume 3, Utrecht, The Netherlands: VSP, 1994; 1-352.
7. Overgaard J, Gonzalez DG, Hulshof MGG, Arcangell G, Dahl O, Mella O, Bentzen SM. Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic maliognant melanoma. Lancet 1995; 345: 540-3.
8. Overgaard J, Gonzalez DG, Hulshof MCCM, Arcangell G, Dahl O, Bentzen SM. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia 1996; 12: 3-20.
9. Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, Vanderzee J, van Putten WLJ, van Rhoon GC, van Dijk JDP, Gonzalez Gonzalez D. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. Int J Radiat Oncol Biol Phys 1996; 35: 731-44.
10. Sneed PK, Stauffer PR, McDermott MW, Diedrich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spey L, Malec MK, Lamb SA, Voss B, Davis RL, Wara WM, Larson DA, Phillips STL, Gutin PH. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastomamultiforme. Int J Radiat Oncol Biol Phys 1998; 40: 287-95.
11. Van Der Zee J, Gonzalez GD, VanRhoon GC, Vandijk JD, Van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumors: A prospective, randomized, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000; 355: 1119-25.
12. Jones EL, Samulski TV, Dewhirst MW, Alvarez-Secord A, Berchuck A, Clarke-Pearson D, Havrilesky LJ, Soper J, Prosnitz LR. A pilot phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. Cancer 2003; 98: 277-82.
13. Van Der Zee J. Heating the patient: A promising approach? Ann Oncol 2002; 13: 1173-84.
14. Alexander HR. Hyperthermia and its modern use in cancer treatment. Cancer 2003; 98: 219-21.
15. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimmer dissociation. Nature 2003; 421: 499-506.
16. Pandita TK. A multifaceted role for ATM in genome maintenance. Expert Rev Mol Med 2003; 5: 1-21.
17. Haber JE. The many interfaces of MRE11. Cell 1998; 95: 583-6.
18. Carney JP, Masser RS, Olivares H, Davis EM, Lebeau M, Yates JR. The hMRE11/hRAD50 protein complex and Nijmegen breakage syndrome: Linkage of double-strand break repair to the cellular DNA damage response. Cell 1998; 93: 477-86.
19. Zhu WG, Seno JD, Beck BD, Dynlacht JR. Translocation of MRE II from the nucleus to the cytoplasm as a mechanism of radiosensitization by heat. Radiat. Res 2001; 156; 95-102.
20. Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetilli O, Chen H-T, Sedelnikova OA: Genomic instability in mice lacking histone H2AX. Science 2002; 296: 922-7.
21. Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A, Bonner RF, Bonner WM, Nussenzweig A. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nature Cell Biol 2003; 5: 675-9.
22. Dewey WC, Hopwood LE, Sapareto SA, Gerweck LE. Cellular responses to combinations of hyperthermia and radiation. Radiology 1977, 123: 463-74.
23. Xu M, Wright WD, Higashikubo R, Wang LL, RotiRoti JL. Thermal radiosensitization of human tumor cell lines with different sensitivities to 41.1°C. Int J Hyperthermia 1999; 15: 279-290.